TTRX Earnings & Financial Statements
Turn Therapeutics Inc.
$11.11
+$0.51(+4.81%)
32
Overall
--
Value
30
Tech
34
Quality
Market Cap
$315.75M
Volume
53.37K
52W Range
$2.57 - $16.45
Target Price
$25.00
TTRX earnings and financial statements: Turn Therapeutics Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
TTRX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | -$5.86M | -$1.80M | -$2.31M |
| EBITDA | -$3.14M | -$1.72M | -$2.25M |
| Net income | -$3.19M | -$1.77M | -$2.29M |
| EPS (diluted) | $-0.12 | $-0.07 | $-0.17 |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total assets | $12.16M | $2.05M | $2.01M |
| Total liabilities | $7.48M | $2.23M | $1.93M |
| Shareholders’ equity | $4.69M | -$177.4K | $85.8K |
| Cash and equivalents | $5.08M | $872.6K | $1.18M |
| Long-term debt | $34.1K | $80.4K | - |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating cash flow | -$2.60M | -$1.36M | -$1.38M |
| Capital expenditure | -$153.0K | - | - |
| Free cash flow | -$2.75M | -$1.46M | -$1.42M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TTRX | $11.11 | +4.8% | 53.37K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |